AUR-VCS-2017-03: An Open-Label, Dose-Exploration Cohort Study Evaluating the Efficacy and Safety ofVoclosporin in Achieving Complete or Partial Remission of Proteinuria in Subjects with Focal SegmentalGlomerulosclerosis

Project: Research project

Project Details

Description

AUR-VCS-2017-03: An Open-Label, Dose-Exploration Cohort Study Evaluating the Efficacy and Safety of Voclosporin in Achieving Complete or Partial Remission of Proteinuria in Subjects with Focal Segmental Glomerulosclerosis
StatusActive
Effective start/end date6/1/1812/31/21

Funding

  • AURINIA PHARMACEUTICALS, INC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.